CASI Pharmaceuticals (CASI) Form 4 CASI Pharmaceuticals / Chi Sing Ho ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

IDG-Accel China Growth Fund III L.P.

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CASI Pharmaceuticals, Inc. [ CASI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/21/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/21/2018		P		2,882,098	A	$3.19(3)	9,126,375	D(1)
Common Stock	03/21/2018		P		204,320	A	$3.19(3)	646,995	I(2)	See Explanation of Responses(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant	$3.69	03/21/2018		P		1,152,839		09/17/2018	03/21/2023	Common Stock	1,152,839	$0.125(3)	1,152,839	D(1)
Warrant	$3.69	03/21/2018		P		1,152,839		09/17/2018	03/21/2023	Common Stock	81,728	$0.125(3)	81,728	I(2)	See Explanation of Responses(2)

1. Name and Address of Reporting Person^*

IDG-Accel China Growth Fund III L.P.

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

IDG-Accel China III Investors L.P.

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

IDG-Accel China Growth Fund III Associates L.P.

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

IDG-Accel China Growth Fund GP III Associates Ltd.

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Ho Chi Sing

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Zhou Quan

(Last) (First) (Middle)

UNIT 5505, THE CENTRE

99 QUEEN'S ROAD CENTRAL

(Street)

K3

(City) (State) (Zip)

Explanation of Responses:

1. These securities are directly owned by IDG-Accel China Growth Fund III L.P. ("IDG-Accel Growth") and may be deemed to be indirectly beneficially owned by the other reporting persons. IDG-Accel China Growth Fund III Associates L.P. ("IDG-Accel Associates") is the general partner of IDG-Accel Growth. IDG-Accel China Growth Fund GP III Associates Ltd. ("IDG-Accel GP") is the general partner of both IDG-Accel Associates and IDG-Accel China III Investors L.P. ("IDG-Accel Investors"). Chi Sing Ho and Quan Zhou are shareholders and directors of IDG-Accel GP. Pursuant to a securities purchase agreement dated as of March 19, 2018 by and among the Issuer and certain investors (the "Purchase Agreement"), IDG-Accel Growth purchased 2,882,098 shares of common stock and warrants to purchase 1,152,839 shares of common stock of the Issuer.

2. These securities are directly owned by IDG-Accel Investors and may be deemed to be indirectly beneficially owned by the other reporting persons. Pursuant to the Purchase Agreement, IDG-Accel Investors purchased 204,320 shares of common stock and warrants to purchase 81,728 shares of common stock of the Issuer.

3. The shares of common stock and the warrants were issued in units consisting of one share of common stock and a right to purchase 0.4 shares of common stock. The purchase price was $3.24 per unit. The filing of this statement by the reporting persons shall not be deemed an admission that such persons are, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this statement.

	/s/ Chi Sing Ho, Director of IDG-Accel China Growth Fund GP III Associates Ltd., the ultimate general partner of IDG-Accel China Growth Fund III L.P., on behalf of IDG-Accel China Growth Fund III L.P.	03/23/2018
	/s/ Chi Sing Ho, Director of IDG-Accel China Growth Fund GP III Associates Ltd., the general partner of IDG-Accel China III Investors L.P., on behalf of IDG-Accel China III Investors L.P.	03/23/2018
	/s/ Chi Sing Ho, Director of IDG-Accel China Growth Fund GP III Associates Ltd., the general partner of IDG-Accel China Growth Fund III Associates L.P., on behalf of IDG-Accel China Growth Fund III Associates L.P.	03/23/2018
	/s/ Chi Sing Ho, Director, on behalf of IDG-Accel China Growth Fund GP III Associates Ltd.	03/23/2018
	/s/ Quan Zhou	03/23/2018
	/s/ Chi Sing Ho	03/23/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.